[go: up one dir, main page]

IL152957A0 - 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity - Google Patents

16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Info

Publication number
IL152957A0
IL152957A0 IL15295701A IL15295701A IL152957A0 IL 152957 A0 IL152957 A0 IL 152957A0 IL 15295701 A IL15295701 A IL 15295701A IL 15295701 A IL15295701 A IL 15295701A IL 152957 A0 IL152957 A0 IL 152957A0
Authority
IL
Israel
Prior art keywords
estrogenic activity
steroid compounds
selective estrogenic
carbocyclic condensed
carbocyclic
Prior art date
Application number
IL15295701A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL152957A0 publication Critical patent/IL152957A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15295701A 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity IL152957A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (1)

Publication Number Publication Date
IL152957A0 true IL152957A0 (en) 2003-06-24

Family

ID=8171601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15295701A IL152957A0 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Country Status (27)

Country Link
US (3) US7868193B2 (pt)
EP (1) EP1294739B1 (pt)
JP (1) JP5095902B2 (pt)
KR (1) KR100769865B1 (pt)
CN (1) CN1235908C (pt)
AR (1) AR028080A1 (pt)
AT (1) ATE293124T1 (pt)
AU (2) AU5838601A (pt)
BR (1) BR0111445A (pt)
CA (1) CA2410220C (pt)
CZ (1) CZ20024014A3 (pt)
DE (1) DE60110069T2 (pt)
DK (1) DK1294739T3 (pt)
ES (1) ES2240454T3 (pt)
HK (1) HK1052012A1 (pt)
HU (1) HUP0301190A3 (pt)
IL (1) IL152957A0 (pt)
MX (1) MXPA02012117A (pt)
NO (1) NO324247B1 (pt)
PE (1) PE20020214A1 (pt)
PL (1) PL203732B1 (pt)
PT (1) PT1294739E (pt)
RU (1) RU2255090C2 (pt)
SK (1) SK286852B6 (pt)
TW (1) TWI225068B (pt)
WO (1) WO2002000682A1 (pt)
ZA (1) ZA200209452B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
CN1235908C (zh) 2006-01-11
WO2002000682A1 (en) 2002-01-03
US7868193B2 (en) 2011-01-11
AU5838601A (en) 2002-01-08
ATE293124T1 (de) 2005-04-15
PL359238A1 (en) 2004-08-23
JP5095902B2 (ja) 2012-12-12
PE20020214A1 (es) 2002-03-13
CA2410220C (en) 2009-04-28
TWI225068B (en) 2004-12-11
DK1294739T3 (da) 2005-08-01
CA2410220A1 (en) 2002-01-03
DE60110069T2 (de) 2005-09-22
JP2004501931A (ja) 2004-01-22
EP1294739B1 (en) 2005-04-13
EP1294739A1 (en) 2003-03-26
SK286852B6 (sk) 2009-06-05
ZA200209452B (en) 2004-02-20
DE60110069D1 (de) 2005-05-19
AR028080A1 (es) 2003-04-23
NO20025793D0 (no) 2002-12-02
RU2255090C2 (ru) 2005-06-27
CZ20024014A3 (cs) 2003-04-16
KR100769865B1 (ko) 2007-10-25
US20100249083A1 (en) 2010-09-30
CN1433426A (zh) 2003-07-30
PL203732B1 (pl) 2009-11-30
KR20030028752A (ko) 2003-04-10
PT1294739E (pt) 2005-06-30
HUP0301190A3 (en) 2010-03-29
HUP0301190A2 (hu) 2003-08-28
HK1052012A1 (en) 2003-08-29
NO20025793L (no) 2002-12-02
US20040102426A1 (en) 2004-05-27
AU2001258386B2 (en) 2005-08-18
MXPA02012117A (es) 2003-06-06
ES2240454T3 (es) 2005-10-16
NO324247B1 (no) 2007-09-17
US20110224183A1 (en) 2011-09-15
BR0111445A (pt) 2003-06-03
SK17072002A3 (sk) 2003-06-03

Similar Documents

Publication Publication Date Title
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
MXPA02012897A (es) Combinaciones de bisfosfonatos, agentes estrigenicos y opcionalmente estrogenos.
CY2325B1 (en) Estrogenic agents.
HK1050254A1 (en) Isolated instructions for isolated execution.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
ZA993345B (en) Nefazodone dosage form.
PL362982A1 (en) Benzothiophene derivative compounds, process for the preparation and use thereof
MXPA02012896A (es) Combinaciones de estatinas, agentes estrogenicos y opcionalmente estrogenos.
PL350360A1 (en) 16−hydroxyestratrienes as selective estrogens
AU2001293512A8 (en) Aldehyde-releasing compounds
HK1046642A1 (en) Novel diphenylethylene compounds.
HK1047596A1 (en) 14, 15-Beta-methylene substituted androgens
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
AU5838601A (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
GB0316320D0 (en) Remedies for dermatophytosis
AU3964400A (en) Selective estrogenic compounds
HK1055954A1 (en) Crystalline therapeutic agent.
ZA200300417B (en) 16alpha-methyl or ethyl substituted estrogens.
HK1042291A1 (en) Dimeric compounds.
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
CA85870S (en) Deodorizing bar
ZA991761B (en) New agent.
HUP0203381A3 (en) 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptane-2-on
ZA200110488B (en) New compounds.

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees